0.40Open0.40Pre Close0 Volume17 Open Interest65.00Strike Price0.00Turnover221.05%IV19.49%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.40Extrinsic Value100Contract SizeAmericanOptions Type-0.0703Delta0.0111Gamma200.60Leverage Ratio-0.3639Theta-0.0003Rho-14.10Eff Leverage0.0074Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet